for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

F D C Ltd

FDC.NS

Latest Trade

162.00INR

Change

2.65(+1.66%)

Volume

11,238

Today's Range

159.00

 - 

163.00

52 Week Range

148.30

 - 

219.00

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Pricing

Previous Close
159.35
Open
159.00
Volume
11,238
3M AVG Volume
0.64
Today's High
163.00
Today's Low
159.00
52 Week High
219.00
52 Week Low
148.30
Shares Out (MIL)
170.97
Market Cap (MIL)
27,244.56
Forward P/E
14.83
Dividend (Yield %)
--

Next Event

Q2 2020 F D C Ltd Earnings Release

Latest Developments

More

FDC Ltd Says Fire Occurred At Roha, Maharashtra Plant On May 3

India's F D C Dec-Qtr Profit Rises

India's F D C Sept-Qtr Profit Falls

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About F D C Ltd

FDC Limited is a pharmaceutical company. The Company is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS). Its therapeutic areas of focus include anti-infectives, gastrointestinals, ophthalmologicals, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology and analgesics. It has a range of functional foods and beverages. Its active pharmaceuticals ingredients (APIs) produced cover a range of therapeutic categories, such as Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate and Timolol Maleate. Its brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm. It has multi-location manufacturing facilities for APIs, as well as finished dosage forms. Its facilities are located at Roha, Waluj and Sinnar in Maharashtra, Verna in Goa and Baddi in Himachal Pradesh.

Industry

Biotechnology & Drugs

Contact Info

142-148, S.V. Road, Jogeshwari (W)

+91.22.30719200

http://www.fdcindia.com/

Executive Leadership

Mohan Anand Chandavarkar

Executive Chairman of the Board, Managing Director

Varsharani Katre

Compliance Officer, Company Secretary

Nandan Mohan Chandavarkar

Joint Managing Director, Executive Director

Ameya Ashok Chandavarkar

Executive Director

Ashok Anand Chandavarkar

Executive Director

Key Stats

2.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, INR)

2017

10.1K

2018

10.8K

2019

10.9K

2020(E)

11.4K
EPS (INR)

2017

10.930

2018

9.760

2019

9.800

2020(E)

10.800
Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

BRIEF-F D C Approves Share Buyback Worth 1.20 Bln Rupees

* APPROVES SHARE BUYBACK WORTH 1.20 BILLION RUPEES Source text for Eikon: Further company coverage:

BRIEF-India's FDC Ltd Dec Qtr Profit Rises

* DEC QUARTER NET PROFIT 426.6 MILLION RUPEES VERSUS 220.3 MILLION RUPEES YEAR AGO

BRIEF-F D C Says UK MHRA Approves Status For Ophthalmic Mfg Facility At Waluj

* UK MHRA APPROVES STATUS FOR OPHTHALMIC MANUFACTURING FACILITY SITUATED AT WALUJ, AURANGABAD Source text for Eikon: Further company coverage:

BRIEF-India's FDC Sept-qtr profit falls

* Sept quarter net profit 648.7 million rupees versus profit 669.9 million rupees year ago

BRIEF-India's F D C March-qtr net PAT rises

* March quarter net pat 490.8 million rupees versus profit 414.5 million rupees year ago

BRIEF-FDC Ltd Dec-qtr profit falls

* Net profit 220.3 million rupees versus 320.9 million rupees year ago

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up